Question 1

How many institutions own QCLS stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own QCLS shares is N/A, representing N/A of the company's common stock.

Question 2

Who are the major shareholders selling Q/C Technologies, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in QCLS by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the QCLS shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned QCLS shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying QCLS stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in QCLS by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of QCLS to its portfolio, raising its holding to - shares of worth -. N/A also increased its QCLS shares holding by N/A which brought its holding to - shares worth -.

Question 4

QCLS's major insiders: who are they?

Accepted Answer

The insider with the most stakes in QCLS is PharmaCyte Biotech, Inc. , 10 percent owner at the company. Additionally, QCLS stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell QCLS stock?

Accepted Answer

Company executives, directors, and other insiders own N/A percent of Q/C Technologies, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which QCLS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Question 6

Which insider recently purchased QCLS stock?

Accepted Answer

There have been 2 transaction(s) during the past 6-months in which Q/C Technologies, Inc. insiders have bought stock, totalling 1779730 shares

Question 7

How much of QCLS does insiders own?

Accepted Answer

Around 1.78M Q/C Technologies, Inc. shares are held by insiders, which represents about N/A of QCLS stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

QCLS 10 percent owner, PharmaCyte Biotech, Inc. holds the largest portfolio of the company's shares. QCLS shares owned by PharmaCyte total nearly 889.87 thousand.

Question 9

Which institution holds the most shares in QCLS?

Accepted Answer

N/A is the largest institutional owner in QCLS which holds - shares worth - or N/A of the total QCLS shares outstanding followed by N/A with ownership of - shares representing N/A of the QCLS ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Q/C Technologies, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the QCLS is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on QCLS's shares?

Accepted Answer

Number of QCLS shares short is null. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding QCLS shares are there?

Accepted Answer

As of today, null shares of QCLS are outstanding.

Question 13

Is there many float in QCLS stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, QCLS has null shares in float.

Question 14

QCLS short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for QCLS is null.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 14, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K
Sep 04, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 14, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K
Sep 04, 2025	PHARMACYTE BIOTECH, INC.	PURCHASE	0.00	889.87K	-	889.87K

QCLS Stock Ownership Breakdown

Q/C Technologies

Stock Outstanding Shares

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions